TSX:CURAPharmaceuticals
Is Now the Right Time to Revisit Curaleaf After Federal Cannabis Reform Talks in 2025?
If you've been wondering whether Curaleaf Holdings is attractively valued right now, you're not alone. We're about to break down all the angles worth considering.
The stock has soared 74.3% year-to-date and is up 31.9% over the past year. However, recent weeks have seen momentum cool off just a bit after a strong run.
This shift in sentiment follows news of broader legislative discussions on U.S. cannabis reform. Renewed debates have sparked investor optimism about the potential for federal...